Sanara MedTech to be Acquired by MiMedx Group for $35.00 Per Share in Cash and Stock
SMTI has more than doubled off its 52-week low of $16.047 on elevated volume (4.6× avg).
Summary
Sanara MedTech Inc. announced its acquisition by MiMedx Group, Inc. for $35.00 per share in a cash and stock deal, a substantial premium for shareholders. The merger will integrate Sanara's surgical product portfolio into MiMedx, creating a larger regenerative medicine company.
Key Events · M&A and Partnerships · SMTI
-
Definitive Merger Agreement Signed
Sanara MedTech Inc. has entered into an Agreement and Plan of Merger with MiMedx Group, Inc., under which MiMedx will acquire Sanara.
-
Acquisition Price Set at $35.00 Per Share
Each Sanara share will be converted into the right to receive $33.00 in cash and 0.4735 shares of MiMedx common stock, totaling $35.00 per share based on MiMedx's recent trading price. This represents a 46% premium to Sanara's 30-day volume weighted average share price as of July 28, 2026.
-
Board Approval and Shareholder Support
The Board of Directors of both companies unanimously approved the transaction. Additionally, certain stockholders, collectively holding approximately 38.9% of Sanara's total voting power, have entered into a voting agreement to support the merger.
-
Strategic Rationale and Financial Benefits
The combination aims to expand MiMedx's surgical footprint, nearly doubling its surgical revenue, and is expected to be immediately accretive to revenue growth, gross margin, and adjusted EBITDA margin, with over $20 million in anticipated run-rate cost synergies.
Analysis · SMTI · Industrial Applications And Services
Sanara MedTech Inc. has entered into a definitive merger agreement to be acquired by MiMedx Group, Inc. for $35.00 per share, representing a significant premium to its recent trading price. This transaction will result in Sanara MedTech becoming a wholly-owned subsidiary of MiMedx, fundamentally altering the company's future and providing a clear exit for shareholders at a favorable valuation. The deal is supported by a voting agreement from stockholders holding approximately 38.9% of Sanara's voting power, increasing the likelihood of shareholder approval.
At the time of this filing, SMTI was trading at $32.69 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $277.2M. The 52-week trading range was $16.05 to $35.95. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.